Previous Nav
Net Change on 25-02-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Max Healthcare Institute Ltd.
Divi's Laboratories Ltd.
Cipla Ltd.
Lupin Ltd.
Lonza Group
Mankind Pharma Ltd.
Jupiter Life Line Hospitals Ltd.
Krishna Institute of Medical Sciences Ltd.
Ami Organics Ltd.
Polymedicure Ltd.
Aether Industries Ltd.
Fortis Healthcare Ltd.
Aster DM Healthcare Ltd.
Laurus Labs Ltd.
Torrent Pharmaceuticals Ltd.
Abbott India Ltd.
Rainbow Children's Medicare Ltd.
Aurobindo Pharma Ltd.
Gland Pharma Ltd.
Alkem Laboratories Ltd.
Biocon Ltd.
Vijaya Diagnostic Centre Ltd.
TREPS
Suven Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Pfizer Ltd.
Gufic Biosciences Ltd.
Concord Biotech Ltd.
Sanofi Consumer Healthcare India Ltd.
182 DAY T-BILL 05.06.25
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Medical Equipment/Supplies/Accessories
Chemicals
16/03/2018
30/01/2015
04/01/2005
06/09/2004
22/09/2003
Cash
Equity
Sovereign
SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹3,521.93 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.
The NAV of SBI Healthcare Opportunities Fund ended up ₹1.44(0.59%)yesterday to ₹246.7742.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai and Pradeep Kesavan.
9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051